Trabectedin Maintenance Post 1st-line in STS

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Maintenance therapy with trabectedin versus observation after first line treatment with doxorubicin of patients with advanced or metastatic soft tissue sarcoma. This is a prospective, multicenter, randomized, open label Phase III trial investigating whether a maintenance treatment with trabectedin, as compared to the observational approach, can prolong progression-free survival in patients with advanced, inoperable and/or metastatic STS after response or stabilisation during first line treatment with doxorubicin.
Epistemonikos ID: dfe02b2cf693592c1699d3eaca3a31d552b6295c
First added on: May 17, 2024